Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Masuda

Showing results (251-260 of 277) with videos related to

Pageof 28
Sort By:
British Journal of Cancer|October 7, 2004
An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinomaT Miyazaki, H Kato, M Nakajima, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 9, 2016
Local recurrence risk after previous salvage mastectomyM Tanabe, T Iwase, Y Okumura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancerN Masuda, K Matsui, S Negoro, et al.
Breast Cancer Research and Treatment|June 14, 2000
Detection of microsatellite alterations in nipple discharge accompanied by breast cancerM Miyazaki, Y Tamaki, I Sakita, et al.
Breast Cancer (Tokyo, Japan)|February 16, 2018
Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trialN Masuda, M Toi, N Yamamoto, et al.
Anticancer Research|August 6, 2000
Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancerT Hirashima, T Komiya, T Nitta, et al.
Journal of Neurovirology|May 19, 2019
HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrityCrystal R Leibrand, Jason J Paris, Austin M Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2019
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancerM E Robson, N Tung, P Conte, et al.
Oncology Reports|April 18, 2000
Identification of a 7-cM region of frequent allelic loss on chromosome band 16p13.3 that is specifically associated with anaplastic thyroid carcinomaM Kadota, Y Tamaki, I Sakita, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2011
Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancerM Wada, M Yamamoto, S Ryuge, et al.
Pageof 28

Showing results (251-260 of 277) with videos related to

Sort By:
Pageof 28
British Journal of Cancer|October 7, 2004
An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinomaT Miyazaki, H Kato, M Nakajima, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 9, 2016
Local recurrence risk after previous salvage mastectomyM Tanabe, T Iwase, Y Okumura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancerN Masuda, K Matsui, S Negoro, et al.
Breast Cancer Research and Treatment|June 14, 2000
Detection of microsatellite alterations in nipple discharge accompanied by breast cancerM Miyazaki, Y Tamaki, I Sakita, et al.
Breast Cancer (Tokyo, Japan)|February 16, 2018
Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trialN Masuda, M Toi, N Yamamoto, et al.
Anticancer Research|August 6, 2000
Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancerT Hirashima, T Komiya, T Nitta, et al.
Journal of Neurovirology|May 19, 2019
HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrityCrystal R Leibrand, Jason J Paris, Austin M Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2019
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancerM E Robson, N Tung, P Conte, et al.
Oncology Reports|April 18, 2000
Identification of a 7-cM region of frequent allelic loss on chromosome band 16p13.3 that is specifically associated with anaplastic thyroid carcinomaM Kadota, Y Tamaki, I Sakita, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2011
Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancerM Wada, M Yamamoto, S Ryuge, et al.
Pageof 28